Clinical Trial Update: Colesevelam Versus Placebo in Cholestatic Pruritus [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing colesevelam to placebo for cholestatic pruritus in chronic liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Colesevelam (colesevelam)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Liver Disease | Phase 2, Phase 3 | Status: COMPLETED